Stock Ratings / Health Care / ONC / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

BeOne Medicines Ltd. (ONC) 12-Month Stock Forecast & Price Target Cone

$371.56 -0.48% NASDAQ • Public Delayed / 60s Snapshot

BeOne Medicines Ltd. (ONC) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (88% profit margin, 11% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $42.25B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+5.9% Base Target

WHALE OPTIONS TUG-OF-WAR:51% Call Buyers ($3.9M)

49% PutsMax Pain: $364.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your ONC Position Size: $10,000

Shares at $371.56: 26.9 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $304.68

$8,200

$-1,800 (-18.0%)

12M Consensus BaseTarget $393.30

$10,585

+$585 (+5.9%)

12M Bull Case BreakoutTarget $464.09

$12,490

+$2,490 (+24.9%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (34 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 23● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	OUTPERFORM	$409	74%	A
Goldman SachsSector Coverage Lead	BUY	$436	69%	B
JP MorganUS Large-Cap Research	HOLD	$349	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live ONC Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

ONC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +25.42%▲ ASCENDING CHANNEL

2026-10-30O $369.8H $376.5L $368.5C $370.3VOL 292.8K

RES: $390.2SUP: $357.0SMA50: $363.2SMA200: $324.9

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ONC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ONC Butterfly Map → + Track ONC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +40.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ONC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ONC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ONC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

ONC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is ONC's 12-month stock price target?

BeOne Medicines Ltd. (ONC) carries a 12-month consensus base price target of $393.3 (+5.9% from $371.56), with a bull-case target of $464.09 and a bear-case floor of $304.68.